{
    "code": "56029743",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56029743",
    "time": "2018-05-25 03:13:19",
    "許可證字號": "衛部醫器輸字第029743號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/06\/02",
    "發證日期": "106\/06\/02",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第三等級",
    "通關簽審文件編號": "DHA05602974304",
    "中文品名": "躍飛莎關節內注射劑",
    "英文品名": "Euflexxa 1% Sodium hyaluronate",
    "效能": "本產品適用於膝關節骨關節炎(Osteoarthritis)所引起的疼痛。",
    "醫器規格": "詳如中文仿單核定本。仿單標籤變更、syringe變更: 詳如中文仿單核定本，原106.7.06仿單標籤核定本予以回收作廢，以下空白。",
    "劑型": "",
    "包裝": "",
    "標籤、仿單及包裝加註": "",
    "": "",
    "醫器主類別一": "N骨科用裝置",
    "醫器次類別一": "N0003關節腔玻尿酸植入物",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "主成分略述": [
        ""
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1509801100  輝凌藥品股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "M240154000  Bio-Technology General (Israel) Ltd.",
        "製造廠廠址": "Be’er Tuvia Industrial Zone, P.O. Box 571, Kiryat Malachi 8310402, Israel",
        "製造廠公司地址": "",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560297430001(107.4.18)-107-04-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56029743&Seq=002&Type=9"
        },
        {
            "title": "560297430001(107.4.18)-107-04-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56029743&Seq=002&Type=8"
        }
    ]
}